Company
Headquarters: Changsha, China
Employees: 27,212
CN¥12.01 Billion
CNY as of Jan. 1, 2025
US$1.65 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
LBX Pharmacy Chain Joint Stock Company operates pharmacy store chain in China. The company operates stores in 21 provincial markets, including Hunan, Jiangsu, Gansu, Shaanxi, Guangxi, Anhui, Zhejiang, Inner Mongolia, Hubei, Tianjin, Henan, Shanghai, Shandong, Guangdong, Hebei, Beijing, Jiangxi, Ningxia, Sichuan, Fujian, and Guizhou. The company was formerly known as Laobaixing Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company was founded in 2001 and is based in Changsha, China.
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥22.63 B |
| EBITDA | CN¥1.60 B |
| Gross Profit TTM | CN¥7.56 B |
| Profit Margin | 3.72% |
| Operating Margin | 5.52% |
| Quarterly Revenue Growth | 1.20% |
LBX Pharmacy Chain Joint Stock Company has the following listings and related stock indices.
Stock: SSE: 603883 wb_incandescent